<DOC>
	<DOCNO>NCT01507597</DOCNO>
	<brief_summary>Diabetes ( type ) recognize high level glucagon circulation . Glucagon known increase blood glucose , might therefore contribute respective disease . Under circumstance gut hormone GLP-1 inhibits glucagon secretion . The investigator aim identify impact GLP-1 glucagon secretion , increase blood glucose level healthy subject , patient type 2 diabetes , patient type 1 diabetes . The investigator think effect GLP-1 glucagon secretion might dependent blood glucose level .</brief_summary>
	<brief_title>The Effect GLP-1 Inhibition Glucagon Secretion</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Patients T2DM Above age 35 year , treatment diet oral antidiabetic medication . Diagnosed T2DM leat three month advance ( WHO criterion ) Normal hemoglobin Informed content Patients T1DM T1DM ( WHO criterion ) PlasmaCpeptid negative due arginintest Normal hemoglobin age &gt; 18 year Informed content Healthy subject Normal fast plasma glucose normal glucose tolerance ( WHO criterion ) Normal hemoglobin Age &gt; 18 year Informed content Patients T2DM Treatment glitazones and/or gliptins Inflammatory bowel disease previous bowel resection without stomy Nephropathy ( serum creatinin &gt; 150 µM and/or albuminuria ) Liver disease ( serum alanineaminotransferase ( ALAT ) and/or serum aspartateaminotransferase ( ASAT ) &gt; 2×normal value ) Medical treatment impossible break 12h . Age &gt; 80 year Patients T1DM Overweight ( BMI &gt; 30 kg/m2 ) Inflammatory bowel disease previous bowel resection without stomy Nephropathy ( serum creatinin &gt; 150 µM and/or albuminuria ) Liver disease ( serum alanineaminotransferase ( ALAT ) and/or serum aspartateaminotransferase ( ASAT ) &gt; 2×normal value ) Medical treatment impossible break 12h ( except treatment insulin ) . Age &gt; 80 year Healthy subject Diabetes Prediabetes ( impaired glucose tolerance and/or impair fast plasma glucose ) First order relative diabetes Overweight ( BMI &gt; 30 kg/m2 ) Inflammatory bowel disease previous bowel resection without stomy Nephropathy ( serum creatinin &gt; 150 µM and/or albuminuria ) Liver disease ( serum alanineaminotransferase ( ALAT ) and/or serum aspartateaminotransferase ( ASAT ) &gt; 2×normal value ) Medical treatment impossible break 12h . Age &gt; 80 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Glucagon-like peptide-1</keyword>
	<keyword>Glucagon</keyword>
	<keyword>Normal physiology</keyword>
	<keyword>T2DM</keyword>
	<keyword>T1DM</keyword>
</DOC>